This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Catalog
ASAP is committed to accelerating the pace of discovery and informing a path to a cure for Parkinson’s disease through collaboration, research-enabling resources, and data sharing. We’ve created this catalog to showcase the research outputs and tools developed by ASAP-funded programs.
Population fraction of Parkinson’s disease attributable to preventable risk factors
Published: The team identified repeated blows to head in sports/combat as a potential new risk factor. 23% of PD cases in females were attributable to pesticides/herbicides exposure, and 30% of PD in males were attributable to pesticides/herbicides, military-related chemical exposures, and repeated blows to the head, and therefore could have potentially been prevented. View original preprint.
Teams
Alpha-synuclein overexpression can drive microbiome dysbiosis in mice
Growing evidence indicates that persons living with Parkinson’s disease (PD) have a unique composition of indigenous gut microbes. Here, the authors used a transgenic mouse strain, which overexpress wild-type human α-syn to test how the gut microbiome composition responds in this model of PD pathology during aging.
A leaky gut dysregulates gene networks in the brain associated with immune activation, oxidative stress, and myelination in a mouse model of colitis
Preprint: The team provides a comprehensive evaluation of multiple systems in a prevalent experimental model of intestinal permeability, which will inform future studies using this model and others, assist in the identification of druggable targets in the gut-brain axis, and contribute to our understanding of the concomitance of intestinal and neuropsychiatric dysfunction.
Teams
pH-Rodo pathogens to monitor phagocytosis in pMacs
pH-Rodo pathogens to monitor phagocytosis in pMacs.
Teams
Structural and functional landscape of α-synuclein fibrilconformations amplified from cerebrospinal fluid
Preprint: Using cryo-electron microscopy to look at alpha-synuclein structurs in the cerebral spinal fluid from those diagnosed with lewy body dementia, the authors identify novel structures highlighting the different ways that alpha-synucelin can fold and assemble.
Teams
Boles_et-al_DSS_time-series
Processed and normalized counts after the removal of low-quality genes and samples. These data are separated into colon (“colon_clean_VST_counts.csv”) and brain (“brain_clean_VST_counts.csv”). The sample key can be found in the metadata at the GEO entry page. This repository contains the code that was used to generate these cleaned counts from the raw counts.
Teams
Alpha-synuclein fibril from spontaneous control
Classification: PROTEIN FIBRIL
Organism(s): Homo sapiens
Expression System: Escherichia coli ‘BL21-Gold(DE3)pLysS AG
Mutation(s): No
Teams
CryoEM structure of amplified alpha-synuclein fibril class B type I with extended core from DLB case X
Classification: PROTEIN FIBRIL
Organism(s): Homo sapiens
Expression System: Escherichia coli ‘BL21-Gold(DE3)pLysS AG
Mutation(s): No
Teams
CryoEM structure of amplified alpha-synuclein fibril class B type II with extended core from DLB case VII
Classification: PROTEIN FIBRIL
Organism(s): Homo sapiens
Expression System: Escherichia coli ‘BL21-Gold(DE3)pLysS AG
Mutation(s): No
Teams
CryoEM structure of amplified alpha-synuclein fibril class B type I with extended core from DLB case VII
Classification: PROTEIN FIBRIL
Organism(s): Homo sapiens
Expression System: Escherichia coli ‘BL21-Gold(DE3)pLysS AG
Mutation(s): No
Teams
CryoEM structures of amplified alpha-synuclein fibril class B type I with compact core from DLB case III
Classification: PROTEIN FIBRIL
Organism(s): Homo sapiens
Expression System: Escherichia coli ‘BL21-Gold(DE3)pLysS AG
Mutation(s): No
Teams
CryoEM structures of amplified alpha-synuclein fibril class B mixed type I/II with extended core from DLB case II
Classification: PROTEIN FIBRIL
Organism(s): Homo sapiens
Expression System: Escherichia coli ‘BL21-Gold(DE3)pLysS AG
Mutation(s): No
Teams
CryoEM structures of amplified alpha-synuclein fibril class B type II with extended core from DLB case I
Classification: PROTEIN FIBRIL
Organism(s): Homo sapiens
Expression System: Escherichia coli BL21(DE3)
Mutation(s): No
Teams
CryoEM structure of amplified alpha-synuclein fibril class A type I with extended core from DLB case X
Classification: PROTEIN FIBRIL
Organism(s): Homo sapiens
Expression System: Escherichia coli ‘BL21-Gold(DE3)pLysS AG
Mutation(s): No
Teams